Venus Concept extends bridge financing and eases covenants

Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potentialVenus Concept ( (VERO) ) just unveiled an update. On January 29, 2026, Venus Concept Inc. and its subsidiaries entered into a consent agreement with Madryn Health Partners that temporarily waived certain minimum liquidity requirements under the company’s Main Street Priority Loan through February 13, 2026 and allowed the February 8, 2026 cash interest payment due under each note to be applied against principal, easing near‑term covenant pressure and cash outflows. On the same date, the parties executed a Twenty Fifth Bridge Loan Amendment extending the bridge loan maturity from January 31, 2026 to February 13, 2026, waiving minimum liquidity covenants over the same period and increasing the delayed draw commitment to $28 million, while also completing a seventeenth delayed drawdown of $2 million at 12% interest to fund general working capital needs, underscoring the company’s continued reliance on high‑cost, secured bridge financing to support operations and manage liquidity. The most recent analyst rating on (VERO) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Venus Concept stock, see the VERO Stock Forecast page. Spark’s Take on VERO Stock According to Spark, TipRanks’ AI Analyst, VERO is a Underperform. The score is driven primarily by weak financial performance (continued losses, cash burn, and high leverage) and bearish technicals (price below all key moving averages). Earnings-call positives (new product launch and debt reduction) provide limited offset, while planned delisting/deregistration adds incremental downside risk. To see Spark’s full report on VERO stock, click here. More about Venus Concept Venus Concept Inc. operates in the medical aesthetics industry through its U.S., Canadian and Israeli subsidiaries, providing equipment and related solutions for aesthetic and cosmetic treatments, with its financing arrangements secured by priority interests in the group’s real and personal property collateral. Average Trading Volume: 7,341,414 Technical Sentiment Signal: Sell Current Market Cap: $2.36M Find detailed analytics on VERO stock on TipRanks’ Stock Analysis page.